PlainRecalls
FDA Drug Moderate Class II Terminated

Lisinopril Tablets USP, 20 mg, 1000-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore MD 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775, India. NDC 68180-0981-03

Reported: April 29, 2020 Initiated: April 20, 2020 #D-1250-2020

Product Description

Lisinopril Tablets USP, 20 mg, 1000-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore MD 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775, India. NDC 68180-0981-03

Reason for Recall

Product Mix-Up: a complaint received indicating mix-up of 10 mg Lisinopril tablets inside of 2 sealed bottles of 20 mg/1000 count bottles.

Details

Units Affected
11,808 bottles
Distribution
Product was distributed Nationwide in the United States.
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Lisinopril Tablets USP, 20 mg, 1000-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore MD 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775, India. NDC 68180-0981-03. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 11,808 bottles.
Why was this product recalled?
Product Mix-Up: a complaint received indicating mix-up of 10 mg Lisinopril tablets inside of 2 sealed bottles of 20 mg/1000 count bottles.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 29, 2020. Severity: Moderate. Recall number: D-1250-2020.